WHO global strategy for the surveillance and monitoring of HIV drug resistance 2012
Overview
The document summarizes a comprehensive package of HIV drug resistance surveys that should be implemented in all countries scaling-up and maintaining populations on antiretroviral therapy (ART). The sections of the strategy include:
- Monitoring HIV drug resistance early warning indicators
- Surveillance of HIV drug resistance in populations prior to treatment initiation and among those receiving ART
- Cross-sectional surveys of HIV drug resistance in adults prior to ART initiation at representative ART clinics
- Cross-sectional surveys of acquired HIV drug resistance in adults and children on ART for more than 12 months at nationally representative ART clinics
- Surveys of HIV drug resistance in children less than 18 months of age
- Surveys of transmitted drug resistance in recently infected populations
- Implementation and funding HIV drug resistance surveillance activities within national ART programmes.